IP Library Granted Patent US 10,724,020
Granted Patent B2
US 10,724,020 · App. 15/380,784 · Granted Jul 28, 2020

Compositions for linking DNA-binding domains and cleavage domains

Inventors: Jeffrey C. Miller (Richmond, CA); David Paschon (Richmond, CA); Edward J. Rebar (Richmond, CA)
Assignee: Sangamo Therapeutics, Inc.
C12N9/22C12N15/52C12N15/62C12N15/907C12Y301/00C07K2319/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,724,020
App. No.
15/380,784
Granted
Jul 28, 2020
Kind
B2
Abstract

Disclosed herein are compositions for linking DNA binding domains and cleavage domains (or cleavage half-domains) to form non-naturally occurring nucleases with alternative configurations. Also described are methods of making and using compositions comprising these linkers.

Claims (14)

1. A dimer comprising first and second fusion molecules, the first fusion molecule comprising a DNA binding domain that binds to a first target site and a first wild-type or engineered cleavage domain and the second fusion molecule comprising a DNA-binding domain that binds to a second target site and a second wild-type or engineered cleavage domain, wherein the first and second cleavage domains dimerize when the DNA-binding domains are bound to the first and second target sites separated by 6 to 7 base pairs, wherein the first fusion molecule comprises an amino acid linker between the DNA-binding domain and the first cleavage domain, wherein the linker is selected from the group consisting of:

(a) when the first and second target sites are separated by 6 base pairs, the linker is selected from the group consisting of: SGSLRGVDPMWH (SEQ ID NO:78); SGRSPEMDWC (SEQ ID NO:62); GASLGPPWCP (SEQ ID NO:80); SGLPMGSYGS (SEQ ID NO:81); SGQSPGDVGF (SEQ ID NO:71); SGAIYARPIE (SEQ ID NO:82); SGAQGSTLDF (SEQ ID NO:83); or SGVKRDSEII (SEQ ID NO:84);

(b) when the first and second target sites are separated by 7 base pairs the linker is selected from the group consisting of: SQATPTLYYTPL (SEQ ID NO:88); SGQPMFSWSD (SEQ ID NO: 109).

2. A dimer according to claim 1 , wherein the DNA-binding domains comprises a zinc finger protein, a TAL-effector domain or a single guide RNA (sgRNA).

3. A dimer according to claim 1 , wherein the linker extends between the N-terminal of the DNA-binding domain and C-terminal of the cleavage domain.

4. The dimer according to claim 1 wherein the linker comprises SGQSPGDVGF (SEQ ID NO:71) or SGVKRDSEII (SEQ ID NO:84).

5. The dimer according to claim 1 , wherein the DNA-binding domains bind to opposite or the same strand of DNA in a double-stranded target DNA.

6. The dimer according to claim 1 , wherein the dimer makes a double- or single-stranded cut in a target double-stranded DNA.

7. A polynucleotide encoding the dimer of claim 1 .

8. An isolated cell comprising one or more dimers according to claim 1 .

9. A method of modifying cellular chromatin in a cell, the method comprising: cleaving the cellular chromatin with a dimer according to claim 1 such that the cellular chromatin is modified, wherein the dimer is introduced into the cell using one or more polynucleotides.

10. The method according to claim 9 , wherein the modification comprises introducing an insertion and/or deletion into the cellular chromatin.

11. The method according to claim 9 , wherein the modification comprises integration of a donor sequence.

12. A kit comprising a dimer according to claim 1 .

Assignments (2)
CHANGE OF NAME Recorded Apr 8, 2020
From: SANGAMO BIOSCIENCES, INC.
To: SANGAMO THERAPEUTICS, INC.
Reel/Frame 052350/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2017
From: MILLER, JEFFREY C.; PASCHON, DAVID; REBAR, EDWARD J.
To: SANGAMO BIOSCIENCES, INC.
Reel/Frame 041478/0388 →
Continuity (2)
Provisional Application 62290065 · Feb 2, 2016
Related Publication 20170218349A1 · Aug 3, 2017
Cited By (1)
US 12,318,427